Company Overview
DoMore Diagnostics was established to develop novel methods in precision medicine for personalized cancer treatment based on advanced research from institutions such as Oslo University Hospital, Oxford University, and University College London.
Mission
The company's mission is to bring AI-powered digital biomarkers closer to clinicians and patients to enable personalized cancer treatment, improve patient outcomes, and reduce healthcare costs.
Leadership
Key management includes Torbjørn Furuseth (CEO & Co-founder), Sepp De Raedt (CTO & Co-founder), Elisabeth M.J. Klaussen (Head of Quality and Regulatory), Andreas Berg Storsve (VP Operations), and Lao Saal (Medical Director).
Scientific Advisory Board
The company benefits from guidance by a scientific advisory board featuring renowned experts such as Dr. John L. Marshall, Dr. Jeanine Roodhart, Dr. Takayuki Yoshino, Dr. Frank A. Sinicrope, Prof. Marc Peeters, Prof. Marco Novelli, and Prof. Hans-Joachim Schmoll.
LinkedIn
Career Opportunities
Currently, there are no open positions available on their careers page, but interested applicants can contact the company through their contact page.